Volume 51, issue 1, January 2021
37 articles in this issue
-
-
Using big data to retrospectively validate the COMPASS-CAT risk assessment model: considerations on methodology
Authors (first, second and last of 8)
-
An international survey of clinicians regarding their management of venous thromboembolism following the initial 3–6 months of anticoagulation
Authors (first, second and last of 7)
-
Hyperacute multi-organ thromboembolic storm in COVID-19: a case report
Authors (first, second and last of 7)
-
-
Impact of Coronavirus Disease 2019 outbreak on acute coronary syndrome admissions: four weeks to reverse the trend
Authors (first, second and last of 11)
-
DVT incidence and risk factors in critically ill patients with COVID-19
Authors (first, second and last of 5)
-
Incidence of pulmonary embolism in non-critically ill COVID-19 patients. Predicting factors for a challenging diagnosis
Authors (first, second and last of 15)
-
Thrombin Generation and other hemostatic parameters in patients with atrial fibrillation in use of warfarin or rivaroxaban
Authors (first, second and last of 14)
-
Incidence and consequences of resuming oral anticoagulant therapy following hematuria and risks of ischemic stroke and major bleeding in patients with atrial fibrillation
Authors (first, second and last of 8)
-
Venous thromboembolism (VTE) risk stratification in general medical patients at an academic medical center
Authors (first, second and last of 5)
-
Stroke and left atrial thrombi after cryoballoon ablation of atrial fibrillation: incidence and predictors. Results from a long-term follow-up
Authors (first, second and last of 16)
-
Right drug, wrong dosage: insights from the PAVE-AF antithrombotic study in older patients with atrial fibrillation
Authors (first, second and last of 12)
-
PEAR1 polymorphisms as a prognostic factor in hemostasis and cardiovascular diseases
Authors (first, second and last of 4)
-
Incidence and characteristics of spontaneous platelet macro-aggregation in acute ischemic stroke
Authors (first, second and last of 8)
-
Network meta-analysis of anticoagulation strategies for venous thromboembolism in patients with cancer
Authors (first, second and last of 7)
-
Ph− myeloproliferative neoplasms and the related risk factors for stroke occurrence: Results from a registry of patients treated with Anagrelide
Authors (first, second and last of 6)
-
Flow cytometric evaluation of platelet–leukocyte conjugate stability over time: methodological implications of sample handling and processing
Authors (first, second and last of 8)
-
Long-term left atrial thrombi after mitral valve replacement
Authors (first, second and last of 7)
-
Comparison of clinical performance of four gastrointestinal bleeding risk scores in Chinese patients with atrial fibrillation receiving oral anticoagulants
Authors (first, second and last of 10)
-
Degree of luminal narrowing and composition of thrombus in plaque erosion
Authors (first, second and last of 10)
-
Treatment of adults with intracranial hemorrhage on apixaban or rivaroxaban with prothrombin complex concentrate products
Authors (first, second and last of 14)
-
Acute revascularization treatments for ischemic stroke in the Stroke Units of Triveneto, northeast Italy: time to treatment and functional outcomes
Authors (first, second and last of 52)
-
-
Safety and efficacy of rt-PA treatment for acute stroke in pseudoxanthoma elasticum: the first report
Authors (first, second and last of 6)
-
Factors influencing early neurological improvement after mechanical thrombectomy among patients with acute basilar artery occlusion: a single center prospective observational cohort study
Authors (first, second and last of 12)
-
Pregnancy and non-pregnancy related immune thrombotic thrombocytopenic purpura in women of reproductive age
Authors (first, second and last of 12)
-
Revascularization outcomes following acute ischemic stroke in patients taking direct oral anticoagulants: a single hospital cohort study
Authors (first, second and last of 4)
-
Impacts of in-hospital workflow on functional outcome in stroke patients treated with endovascular thrombectomy
Authors (first, second and last of 11)
-
Long-term outcome of patients with ST-segment elevation myocardial infarction treated with low-dose intracoronary thrombolysis during primary percutaneous coronary intervention: the 5-year results of the DISSOLUTION Trial
Authors (first, second and last of 6)
-
Value-based assessment of implementing a Pulmonary Embolism Response Team (PERT)
Authors (first, second and last of 6)
-
Anti-coagulation for COVID-19 treatment: both anti-thrombotic and anti-inflammatory?
Authors (first, second and last of 7)
-
-
Aortic thrombus in patients with severe COVID-19: review of three cases
Authors (first, second and last of 9)
-
Argatroban for therapeutic anticoagulation for heparin resistance associated with Covid-19 infection
Authors (first, second and last of 7)
-
Correction to: Treatment of adults with intracranial hemorrhage on apixaban or rivaroxaban with prothrombin complex concentrate products
Authors (first, second and last of 14)
-
Correction to: Treatment of adults with intracranial hemorrhage on apixaban or rivaroxaban with prothrombin complex concentrate products
Authors (first, second and last of 14)
